Bellerophon Therapeutics在盘前股价暴跌39%,因公司将被纳斯达克摘牌。查看全文
临床治疗药物公司Bellerophon(BLPH.O)盘初跳涨18%,触及熔断。 网页链接
$柏勒罗丰治疗(BLPH)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001718111-20-000003 Act: 34 Size: 89 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001760460-20-000002 Size: 12 KB 网页链接
$柏勒罗丰治疗(BLPH)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001718111-20-000002 Act: 34 Size: 61 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001104659-20-064230 Act: 34 Size: 386 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-20-064223 Act: 33 Size: 498 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-20-064227 Act: 33 Size: 435 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-20-063155 Act: 33 Size: 523 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001600132-20-000059 Act: 34 Size: 3 MB 网页链接
$柏勒罗丰治疗(BLPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001600132-20-000060 Act: 34 Size: 190 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001600132-20-000056 Act: 34 Size: 68 KB 网页链接